The Potential Anticancer Potency of Kolaviron on Colorectal Adenocarcinoma (Caco-2) Cells


Цитировать

Полный текст

Аннотация

Background:Globally, colorectal cancer (CRC) is categorized as the third type of cancer associated with mortalities. Chemotherapeutic drugs such as cisplatin can be used to treat cancer-affected patients. However, several adverse effects are associated with its application. This motivated the researchers to search for alternatives that are more efficient and have fewer undesirable effects. Kolaviron is a bioflavonoid that has been reported to have antioxidant and anti-inflammatory properties.

Aim:This study aimed to compare the anticancer effects of kolaviron and cisplatin on Caco-2 cells. The IC50 of kolaviron and cisplatin were calculated, and redox status, apoptotic-related proteins and the cell cycle were also examined.

Methods:Caco-2 cells were treated with kolaviron (⅟3 and ½ of IC50 dose) and cisplatin (IC50 dose) for 24 h and 48 h. Cell viability was assessed using the MTT protocol. Redox status and apoptotic-related proteins, in addition to the cell cycle, were examined.

Results:The MTT assay showed the IC50 of kolaviron is 9.49 µg/mL, and that of cisplatin is 2.71 µg/ml against Caco-2 cells. Further, both doses of kolaviron significantly increased the leakage of lactate dehydrogenase (LDH), the production of reactive oxygen species (ROS), and lipoperoxidation (LPO), besides decreasing the antioxidant potency of tumor cells as revealed by the diminished reduced glutathione (GSH). At the molecular level, a significant increase in the levels of p53, cytochrome c, Bax, and caspase 3 was recorded, coupled with a decrease in the level of Bcl2, after treating the Caco-2 cells with kolaviron and cisplatin. Furthermore, kolaviron demonstrated asserted more effects on apoptosis and increased cell percentage in the subG1 phase. In addition, a notable decrease in the expression of proliferating cell nuclear antigen (PCNA) and cyclin D1 is associated with an increase in the expression of tumor protein P53 (TP53) in kolaviron-treated Caco-2 cells cancerous cells.

Conclusion:Conclusively, these data suggest that kolaviron has a potential antitumor capacity against colorectal cancer via multiple pathways, including enhancement of ROS production, redox status, p53 pathway, and apoptosis. Therefore, this study authenticated the capability of kolaviron as a valuable chemotherapeutic agent.

Об авторах

Hussam Althagafi

Department of Biology, Faculty of Science and Arts, Al-Baha University

Автор, ответственный за переписку.
Email: info@benthamscience.net

Список литературы

  1. Othman, M.S.; Al-Bagawi, A.H.; Obeidat, S.T.; Fareid, M.A.; Habotta, O.A.; Moneim, A.E.A. Antitumor activity of zinc nanoparticles synthesized with berberine on human epithelial colorectal adenocarcinoma (Caco-2) cells through acting on Cox-2/NF-κB and p53 pathways. Anticancer. Agents Med. Chem., 2022, 22(10), 2002-2010. doi: 10.2174/1871520621666211004115839 PMID: 34607550
  2. Jaferian, S.; Negahdari, B.; Eatemadi, A. Colon cancer targeting using conjugates biomaterial 5-flurouracil. Biomed. Pharmacother., 2016, 84, 780-788. doi: 10.1016/j.biopha.2016.10.004 PMID: 27721176
  3. Messersmith, W.A. NCCN guidelines updates: Management of metastatic colorectal cancer. J. Natl. Compr. Canc. Netw., 2019, 17(5), 599-601.
  4. El-Garawani, I.M.; El-Nabi, S.H.; Dawoud, G.T.; Esmail, S.M.; Abdel Moneim, A.E. Triggering of apoptosis and cell cycle arrest by fennel and clove oils in Caco-2 cells: The role of combination. Toxicol. Mech. Methods, 2019, 29(9), 710-722. doi: 10.1080/15376516.2019.1650149 PMID: 31364915
  5. Galluzzi, L.; Vitale, I.; Michels, J.; Brenner, C.; Szabadkai, G.; Harel-Bellan, A.; Castedo, M.; Kroemer, G. Systems biology of cisplatin resistance: Past, present and future. Cell Death Dis., 2014, 5(5), e1257-e1257. doi: 10.1038/cddis.2013.428 PMID: 24874729
  6. Farombi, E.O.; Adedara, I.A.; Ajayi, B.O.; Ayepola, O.R.; Egbeme, E.E. Kolaviron, a natural antioxidant and anti-inflammatory phytochemical prevents dextran sulphate sodium-induced colitis in rats. Basic Clin. Pharmacol. Toxicol., 2013, 113(1), 49-55. doi: 10.1111/bcpt.12050 PMID: 23336970
  7. Farombi, E.O.; Abarikwu, S.O.; Adedara, I.A.; Oyeyemi, M.O. Curcumin and kolaviron ameliorate di-n-butylphthalate-induced testicular damage in rats. Basic Clin. Pharmacol. Toxicol., 2007, 100(1), 43-48. doi: 10.1111/j.1742-7843.2007.00005.x PMID: 17214610
  8. Adaramoye, O.A.; Adeyemi, E.O. Hypoglycaemic and hypolipidaemic effects of fractions from kolaviron, a biflavonoid complex from Garcinia Kola in streptozotocin-induced diabetes mellitus rats. J. Pharm. Pharmacol., 2010, 58(1), 121-128. doi: 10.1211/jpp.58.1.0015 PMID: 16393472
  9. Adaramoye, O.A.; Nwaneri, V.O.; Anyanwu, K.C.; Farombi, E.O.; Emerole, G.O. Possible anti‐atherogenic effect of kolaviron (a Garcinia kola seed extract) in hypercholesterolaemic rats. Clin. Exp. Pharmacol. Physiol., 2005, 32(1-2), 40-46. doi: 10.1111/j.1440-1681.2005.04146.x PMID: 15730433
  10. Ajayi, B.O.; Adedara, I.A.; Emeka, O.C.; Awoyinka, P.B.; Beckley, O.O.; Adeleye, A.A.; Farombi, E.O. Kolaviron ameliorates chronic colitis induced by prolonged oral administration of Dextran Sulphate Sodium in Balb/c mice. Eur. J. Med. Chem. Reprts, 2022, 6, 100071. doi: 10.1016/j.ejmcr.2022.100071
  11. Farombi, E.O.; Shrotriya, S.; Surh, Y.J. Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-κB and AP-1. Life Sci., 2009, 84(5-6), 149-155. doi: 10.1016/j.lfs.2008.11.012 PMID: 19081081
  12. Blake, C.; Adetokunbo, O.; Adedapo, A.; Omobowale, T.; Yakubu, M. Kolaviron‐induced inhibition of h1299 lung cancer cells growth and survival via PKA/P13K pathways. FASEB J., 2015, 29(S1), LB539. doi: 10.1096/fasebj.29.1_supplement.lb539
  13. Iwu, M.M. Antihepatoxic constituents of Garcinia kola seeds. Experientia, 1985, 41(5), 699-700. doi: 10.1007/BF02007729 PMID: 3838940
  14. Cotterill, P.J.; Scheinmann, F.; Stenhouse, I.A. Extractives from guttiferae. Part 34. Kolaflavanone, a new biflavanone from the nuts of Garcinia kola Heckel. Applications of 13C nuclear magnetic resonance in elucidation of the structures of flavonoids. J. Chem. Soc., Perkin Trans. 1, 1978, (6), 532-539. doi: 10.1039/p19780000532
  15. Tolosa, L.; Donato, M.T.; Gómez-Lechón, M.J. General cytotoxicity assessment by means of the MTT assay. Methods Mol. Biol., 2015, 1250, 333-348. doi: 10.1007/978-1-4939-2074-7_26 PMID: 26272156
  16. Hafner, A.; Lovrić, J.; Voinovich, D.; Filipović-Grčić, J. Melatonin-loaded lecithin/chitosan nanoparticles: Physicochemical characterisation and permeability through Caco-2 cell monolayers. Int. J. Pharm., 2009, 381(2), 205-213. doi: 10.1016/j.ijpharm.2009.07.001 PMID: 19596430
  17. Wang, X.; Roper, M.G. Measurement of DCF fluorescence as a measure of reactive oxygen species in murine islets of Langerhans. Anal. Methods, 2014, 6(9), 3019-3024. doi: 10.1039/C4AY00288A PMID: 24955137
  18. Ohkawa, H.; Ohishi, N.; Yagi, K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 1979, 95(2), 351-358. doi: 10.1016/0003-2697(79)90738-3 PMID: 36810
  19. Ellman, G.L. Tissue sulfhydryl groups. Arch. Biochem. Biophys., 1959, 82(1), 70-77. doi: 10.1016/0003-9861(59)90090-6 PMID: 13650640
  20. Fang, B.; Fu, G.; Agniswamy, J.; Harrison, R.W.; Weber, I.T. Caspase-3 binds diverse P4 residues in peptides as revealed by crystallography and structural modeling. Apoptosis, 2009, 14(5), 741-752. doi: 10.1007/s10495-009-0333-y PMID: 19283487
  21. Petros, A.M.; Medek, A.; Nettesheim, D.G.; Kim, D.H.; Yoon, H.S.; Swift, K.; Matayoshi, E.D.; Oltersdorf, T.; Fesik, S.W. Solution structure of the antiapoptotic protein bcl-2. Proc. Natl. Acad. Sci. USA, 2001, 98(6), 3012-3017. doi: 10.1073/pnas.041619798 PMID: 11248023
  22. Frisch, M. Spectroscopic evaluation of the molecular structures of di-µ-Chlorobis(1,5-Cyclooctadiene) Iridium (I) and Rhodium (I) Complexes. J Appl. Math. Phy., 2015, 3(2), 1399207.
  23. Wikipedia. Discovery studio. 2008. Available From: https://en.wikipedia.org/wiki/Discovery_Studio
  24. Othman, M.S.; Aboelnaga, S.M.; Habotta, O.A.; Moneim, A.E.A.; Hussein, M.M. The potential therapeutic role of green-synthesized selenium nanoparticles using carvacrol in human breast cancer MCF-7 cells. Appl. Sci. (Basel), 2023, 13(12), 7039. doi: 10.3390/app13127039
  25. Lin, S.R.; Fu, Y.S.; Tsai, M.J.; Cheng, H.; Weng, C.F. Natural compounds from herbs that can potentially execute as autophagy inducers for cancer therapy. Int. J. Mol. Sci., 2017, 18(7), 1412. doi: 10.3390/ijms18071412 PMID: 28671583
  26. Oyagbemi, A. Antiproliferative effect of kolaviron, a biflavonoid complex from the seed of Garcinia kola on vascular smooth muscle cells (VSMs) and A549 cancer cell line. The FASEB J, 2015, 29, 945-17.
  27. Farombi, E.O.; Tahnteng, J.G.; Agboola, A.O.; Nwankwo, J.O.; Emerole, G.O. Chemoprevention of 2-acetylaminofluorene-induced hepatotoxicity and lipid peroxidation in rats by kolaviron-A Garcinia kola seed extract. Food Chem. Toxicol., 2000, 38(6), 535-541. doi: 10.1016/S0278-6915(00)00039-9 PMID: 10828505
  28. Olatunde, F.E.; Møller, P.; Dragsted, L.O. Ex-vivo and in vitro protective effects of kolaviron against oxygen-derived radical-induced DNA damage and oxidative stress in human lymphocytes and rat liver cells. Cell Biol. Toxicol., 2004, 20(2), 71-82. doi: 10.1023/B:CBTO.0000027916.61347.bc PMID: 15242183
  29. Farombi, E.O.; Adepoju, B.F.; Ola-Davies, O.E.; Emerole, G.O. Chemoprevention of aflatoxin B1-induced genotoxicity and hepatic oxidative damage in rats by kolaviron, a natural biflavonoid of Garcinia kola seeds. Eur. J. Cancer Prev., 2005, 14(3), 207-214. doi: 10.1097/00008469-200506000-00003 PMID: 15901988
  30. Brown, D.I.; Griendling, K.K. Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ. Res., 2015, 116(3), 531-549. doi: 10.1161/CIRCRESAHA.116.303584 PMID: 25634975
  31. Agullo, G.; Gamet, L.; Besson, C.; Demigné, C.; Rémésy, C. Quercetin exerts a preferential cytotoxic effect on active dividing colon carcinoma HT29 and Caco-2 cells. Cancer Lett., 1994, 87(1), 55-63. doi: 10.1016/0304-3835(94)90409-X PMID: 7954370
  32. Yücel, Ç.; Değim, Z.; Yılmaz, Ş. Development of Cisplatin-loaded liposome and evaluation of transport properties through Caco-2 cell line. Turkish J. Pharm. Sci., 2016, 13(1), 95-108. doi: 10.5505/tjps.2016.32032
  33. Chen, H.M.; Lai, Z.Q.; Liao, H.J.; Xie, J.H.; Xian, Y.F.; Chen, Y.L.; Ip, S.P.; Lin, Z.X.; Su, Z.R. Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells. Int. J. Mol. Med., 2018, 41(3), 1447-1454. doi: 10.3892/ijmm.2018.3372 PMID: 29328398
  34. Fernández de Mattos, S.; Villalonga, P.; Clardy, J.; Lam, E.W.F. FOXO3a mediates the cytotoxic effects of cisplatin in colon cancer cells. Mol. Cancer Ther., 2008, 7(10), 3237-3246. doi: 10.1158/1535-7163.MCT-08-0398 PMID: 18852127
  35. Felth, J.; Rickardson, L.; Rosén, J.; Wickström, M.; Fryknäs, M.; Lindskog, M.; Bohlin, L.; Gullbo, J. Cytotoxic effects of cardiac glycosides in colon cancer cells, alone and in combination with standard chemotherapeutic drugs. J. Nat. Prod., 2009, 72(11), 1969-1974. doi: 10.1021/np900210m PMID: 19894733
  36. Lin, X.; Ramamurthi, K.; Mishima, M.; Kondo, A.; Christen, R.D.; Howell, S.B. P53 modulates the effect of loss of DNA mismatch repair on the sensitivity of human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin. Cancer Res., 2001, 61(4), 1508-1516. PMID: 11245458
  37. Saber, M.M.; Al-mahallawi, A.M.; Nassar, N.N.; Stork, B.; Shouman, S.A. Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes. BMC Cancer, 2018, 18(1), 822. doi: 10.1186/s12885-018-4727-5 PMID: 30111296
  38. Yokoo, S.; Masuda, S.; Yonezawa, A.; Terada, T.; Katsura, T.; Inui, K. Significance of organic cation transporter 3 (SLC22A3) expression for the cytotoxic effect of oxaliplatin in colorectal cancer. Drug Metab. Dispos., 2008, 36(11), 2299-2306. doi: 10.1124/dmd.108.023168 PMID: 18710896
  39. Turktekin, M.; Konac, E.; Onen, H.I.; Alp, E.; Yilmaz, A.; Menevse, S. Evaluation of the effects of the flavonoid apigenin on apoptotic pathway gene expression on the colon cancer cell line (HT29). J. Med. Food, 2011, 14(10), 1107-1117. doi: 10.1089/jmf.2010.0208 PMID: 21548803
  40. Gurunathan, S.; Qasim, M.; Park, C.; Yoo, H.; Kim, J.H.; Hong, K. Cytotoxic potential and molecular pathway analysis of silver nanoparticles in human colon cancer cells HCT116. Int. J. Mol. Sci., 2018, 19(8), 2269. doi: 10.3390/ijms19082269 PMID: 30072642
  41. Bhardwaj, M.; Cho, H.J.; Paul, S.; Jakhar, R.; Khan, I.; Lee, S.J.; Kim, B.Y.; Krishnan, M.; Khaket, T.P.; Lee, H.G.; Kang, S.C. Vitexin induces apoptosis by suppressing autophagy in multi-drug resistant colorectal cancer cells. Oncotarget, 2018, 9(3), 3278-3291. doi: 10.18632/oncotarget.22890 PMID: 29423046
  42. Kwon, M.; Oh, T.; Jang, M.; Kim, G.H.; Kim, J.H.; Ryu, H.W.; Oh, S.R.; Jang, J.H.; Ahn, J.S.; Ko, S.K. Kurarinone induced p53-independent G0/G1 cell cycle arrest by degradation of K-RAS via WDR76 in human colorectal cancer cells. Eur. J. Pharmacol., 2022, 923, 174938. doi: 10.1016/j.ejphar.2022.174938 PMID: 35381263
  43. Natarajan, N.; Thamaraiselvan, R.; Lingaiah, H.; Srinivasan, P.; Maruthaiveeran, P.B. Effect of flavonone hesperidin on the apoptosis of human mammary carcinoma cell line MCF-7. Biomed. Preventive Nutrition, 2011, 1(3), 207-215. doi: 10.1016/j.bionut.2011.07.001
  44. Zhou, J.; Li, P.; Xue, X.; He, S.; Kuang, Y.; Zhao, H.; Chen, S.; Zhi, Q.; Guo, X. Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species. Toxicol. Lett., 2013, 222(2), 139-145. doi: 10.1016/j.toxlet.2013.07.022 PMID: 23916687
  45. Circu, M.L.; Aw, T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med., 2010, 48(6), 749-762. doi: 10.1016/j.freeradbiomed.2009.12.022 PMID: 20045723
  46. Abarikwu, S.O.; Farombi, E.O.; Pant, A.B. Biflavanone-kolaviron protects human dopaminergic SH-SY5Y cells against atrazine induced toxic insult. Toxicol. In Vitro, 2011, 25(4), 848-858. doi: 10.1016/j.tiv.2011.02.005 PMID: 21333729
  47. Juan, M.E.; Wenzel, U.; Daniel, H.; Planas, J.M. Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cells. J. Agric. Food Chem., 2008, 56(12), 4813-4818. doi: 10.1021/jf800175a PMID: 18522405
  48. Das, A.; Banik, N.L.; Ray, S.K. Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer, 2010, 116(1), 164-176. doi: 10.1002/cncr.24699 PMID: 19894226
  49. Lin, Y.; Shi, R.; Wang, X.; Shen, H.M. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr. Cancer Drug Targets, 2008, 8(7), 634-646. doi: 10.2174/156800908786241050 PMID: 18991571
  50. Galati, G.; O’Brien, P.J. Potential toxicity of flavonoids and other dietary phenolics: Significance for their chemopreventive and anticancer properties. Free Radic. Biol. Med., 2004, 37(3), 287-303. doi: 10.1016/j.freeradbiomed.2004.04.034 PMID: 15223063
  51. Othman, M.S.; Obeidat, S.T.; Al-Bagawi, A.H.; Fareid, M.A.; Fehaid, A.; Abdel Moneim, A.E. Green-synthetized selenium nanoparticles using berberine as a promising anticancer agent. J. Integr. Med., 2022, 20(1), 65-72. doi: 10.1016/j.joim.2021.11.002 PMID: 34802980
  52. Park, B.H.; Lim, J.E.; Jeon, H.G.; Il Seo, S.; Lee, H.M.; Choi, H.Y.; Jeon, S.S.; Jeong, B.C. Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2. Oncotarget, 2016, 7(39), 63870-63886. doi: 10.18632/oncotarget.11563 PMID: 27564099
  53. Kleih, M.; Böpple, K.; Dong, M.; Gaißler, A.; Heine, S.; Olayioye, M.A.; Aulitzky, W.E.; Essmann, F. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death Dis., 2019, 10(11), 851. doi: 10.1038/s41419-019-2081-4 PMID: 31699970
  54. Yang, Z.; Guo, F.; Albers, A.E.; Sehouli, J.; Kaufmann, A.M. Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines. Biomed. Pharmacother., 2019, 113, 108727. doi: 10.1016/j.biopha.2019.108727 PMID: 30870721
  55. Fleury, C.; Mignotte, B.; Vayssière, J.L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie, 2002, 84(2-3), 131-141. doi: 10.1016/S0300-9084(02)01369-X PMID: 12022944
  56. Martins, N.M.; Santos, N.A.G.; Curti, C.; Bianchi, M.L.P.; Santos, A.C. Cisplatin induces mitochondrial oxidative stress with resultant energetic metabolism impairment, membrane rigidification and apoptosis in rat liver. J. Appl. Toxicol., 2008, 28(3), 337-344. doi: 10.1002/jat.1284 PMID: 17604343
  57. Durgo, K. Effects of flavonoids on glutathione level, lipid peroxidation and cytochrome P450 CYP1A1 expression in human laryngeal carcinoma cell lines. Food Technol. Biotechnol., 2007, 45(1), 69.
  58. Martín, M.A.; Ramos, S.; Mateos, R.; Izquierdo-Pulido, M.; Bravo, L.; Goya, L. Protection of human HepG2 cells against oxidative stress by the flavonoid epicatechin. Phytother. Res., 2010, 24(4), 503-509. doi: 10.1002/ptr.2961 PMID: 20041424
  59. Park, H.J.; Choi, Y.J.; Lee, J.H.; Nam, M.J. Naringenin causes ASK1-induced apoptosis via reactive oxygen species in human pancreatic cancer cells. Food Chem. Toxicol., 2017, 99, 1-8. doi: 10.1016/j.fct.2016.11.008 PMID: 27838343
  60. Yu, W.; Chen, Y.; Dubrulle, J.; Stossi, F.; Putluri, V.; Sreekumar, A.; Putluri, N.; Baluya, D.; Lai, S.Y.; Sandulache, V.C. Cisplatin generates oxidative stress which is accompanied by rapid shifts in central carbon metabolism. Sci. Rep., 2018, 8(1), 4306. doi: 10.1038/s41598-018-22640-y PMID: 29523854
  61. El-Demiry, S.M.; El-Yamany, M.; El-Gendy, S.M.; Salem, H.A.; Saber, M.M. Necroptosis modulation by cisplatin and sunitinib in hepatocellular carcinoma cell line. Life Sci., 2022, 301, 120594. doi: 10.1016/j.lfs.2022.120594 PMID: 35500680
  62. Wang, H.Y.; Yu, H.Z.; Huang, S.M.; Zheng, Y.L. p53, Bcl-2 and cox-2 are involved in berberine hydrochloride-induced apoptosis of HeLa229 cells. Mol. Med. Rep., 2016, 14(4), 3855-3861. doi: 10.3892/mmr.2016.5696 PMID: 27601129
  63. Huang, H.; Chen, A.Y.; Ye, X.; Guan, R.; Rankin, G.O.; Chen, Y.C. Galangin, a flavonoid from lesser galangal, induced apoptosis via p53-dependent pathway in ovarian cancer cells. Molecules, 2020, 25(7), 1579. doi: 10.3390/molecules25071579 PMID: 32235536
  64. El-Shorbagy, H.M.; Eissa, S.M.; Sabet, S.; El-Ghor, A.A. Apoptosis and oxidative stress as relevant mechanisms of antitumor activity and genotoxicity of ZnO-NPs alone and in combination with N-acetyl cysteine in tumor-bearing mice. Int. J. Nanomed., 2019, 14, 3911-3928. doi: 10.2147/IJN.S204757 PMID: 31213808
  65. Shih-Wei, W. ZnO nanoparticles induced caspase-dependent apoptosis in gingival squamous cell carcinoma through mitochondrial dysfunction and p70S6K signaling pathway. Int. J. Mol. Sci., 2020, 21(5), 1612.
  66. Kuwana, T.; Newmeyer, D.D. Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr. Opin. Cell Biol., 2003, 15(6), 691-699. doi: 10.1016/j.ceb.2003.10.004 PMID: 14644193
  67. Chen, W.-S. Bcl-2-family proteins and the role of mitochondria in apoptosis.Enhancement of p53-mutant human colorectal cancer cells radiosensitivity by flavonoid fisetin. Int. J. Radiat. Oncol. Biol. Phys., 2010, 77(5), 1527-1535. doi: 10.1016/j.ijrobp.2010.02.043
  68. Xavier, C.P.R.; Lima, C.F.; Rohde, M.; Pereira-Wilson, C. Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation. Cancer Chemother. Pharmacol., 2011, 68(6), 1449-1457. doi: 10.1007/s00280-011-1641-9 PMID: 21479885
  69. Li, J.; Cheng, Y.; Qu, W.; Sun, Y.; Wang, Z.; Wang, H.; Tian, B. Fisetin, a dietary flavonoid, induces cell cycle arrest and apoptosis through activation of p53 and inhibition of NF-kappa B pathways in bladder cancer cells. Basic Clin. Pharmacol. Toxicol., 2011, 108(2), 84-93. doi: 10.1111/j.1742-7843.2010.00613.x PMID: 21054790
  70. Katiyar, S.K.; Roy, A.M.; Baliga, M.S. Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation. Mol. Cancer Ther., 2005, 4(2), 207-216. doi: 10.1158/1535-7163.207.4.2 PMID: 15713892
  71. An, S.H.; Kang, J.H.; Kim, D.H.; Lee, M.S. Vitamin C increases the apoptosis via up-regulation p53 during cisplatin treatment in human colon cancer cells. BMB Rep., 2011, 44(3), 211-216. doi: 10.5483/BMBRep.2011.44.3.211 PMID: 21429301
  72. Wu, X.; Lu, Y.; Qin, X. Combination of Compound Kushen Injection and cisplatin shows synergistic antitumor activity in p53-R273H/P309S mutant colorectal cancer cells through inducing apoptosis. J. Ethnopharmacol., 2022, 283, 114690. doi: 10.1016/j.jep.2021.114690 PMID: 34597653
  73. Yuan, J. USP39 attenuates the antitumor activity of cisplatin on colon cancer cells dependent on p53. Cell Biol. Toxicol., 2021, 1-16. PMID: 34822033
  74. Siddik, Z.H. Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene, 2003, 22(47), 7265-7279. doi: 10.1038/sj.onc.1206933 PMID: 14576837
  75. Aloufi, A.S.; Habotta, O.A.; Abdelfattah, M.S.; Habib, M.N.; Omran, M.M.; Ali, S.A.; Abdel Moneim, A.E.; Korany, S.M.; Alrajhi, A.M. Resistomycin suppresses prostate cancer cell growth by instigating oxidative stress, mitochondrial apoptosis, and cell cycle arrest. Molecules, 2023, 28(23), 7871. doi: 10.3390/molecules28237871 PMID: 38067602
  76. Fernandez-Gil, B.I.; Guerra-Librero, A.; Shen, Y.Q.; Florido, J.; Martínez-Ruiz, L.; García-López, S.; Adan, C.; Rodríguez-Santana, C.; Acuña-Castroviejo, D.; Quiñones-Hinojosa, A.; Fernández-Martínez, J.; Abdel Moneim, A.E.; López, L.C.; Rodríguez Ferrer, J.M.; Escames, G. Melatonin enhances cisplatin and radiation cytotoxicity in head and neck squamous cell carcinoma by stimulating mitochondrial ros generation, apoptosis, and autophagy. Oxid. Med. Cell. Longev., 2019, 2019, 1-12. doi: 10.1155/2019/7187128 PMID: 30944696
  77. Kim, S.Y.; Kim, J.E.; Lee, K.W.; Lee, H.J. Lactococcus lactis ssp. lactis inhibits the proliferation of SNU-1 human stomach cancer cells through induction of G0/G1 cell cycle arrest and apoptosis via p53 and p21 expression. Ann. N. Y. Acad. Sci., 2009, 1171(1), 270-275. doi: 10.1111/j.1749-6632.2009.04721.x PMID: 19723065
  78. Al-Mohanna, M.A.; Al-Khodairy, F.M.; Krezolek, Z.; Bertilsson, P.A.; Al-Houssein, K.A.; Aboussekhra, A. p53 is dispensable for UV-induced cell cycle arrest at late G1 in mammalian cells. Carcinogenesis, 2001, 22(4), 573-578. doi: 10.1093/carcin/22.4.573 PMID: 11285191
  79. Lim, D.Y.; Jeong, Y.; Tyner, A.L.; Park, J.H.Y. Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. Am. J. Physiol. Gastrointest. Liver Physiol., 2007, 292(1), G66-G75. doi: 10.1152/ajpgi.00248.2006 PMID: 16901994
  80. Wang, Z.; Lin, W.; Shi, M.; Hou, Y.; Liu, J.; Huang, Z.; Zhang, X.; Yang, Y.; Liu, B.; Yang, Z.; Ma, W. Involucrasin B inhibits the proliferation of Caco-2 cells by regulating the TGFβ/SMAD2-3-4 pathway. Molecules, 2024, 29(3), 686. doi: 10.3390/molecules29030686 PMID: 38338430
  81. Aubrey, B.J.; Kelly, G.L.; Janic, A.; Herold, M.J.; Strasser, A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell Death Differ., 2018, 25(1), 104-113. doi: 10.1038/cdd.2017.169 PMID: 29149101
  82. Williams, A.B.; Schumacher, B. p53 in the DNA-damage-repair process. Cold Spring Harb. Perspect. Med., 2016, 6(5), a026070. doi: 10.1101/cshperspect.a026070 PMID: 27048304

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Bentham Science Publishers, 2024